• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

V-ets 红细胞生成病毒 E26 癌基因同源物(禽)/三叶因子 3/高分子量细胞角蛋白三重免疫染色:前列腺癌的一种新的基于组织的生物标志物,具有潜在的临床应用。

V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application.

机构信息

Department of Pathology and Laboratory Medicine, Weill Medical College of Cornell University, New York, NY 10065, USA.

出版信息

Hum Pathol. 2013 Oct;44(10):2282-92. doi: 10.1016/j.humpath.2013.05.010. Epub 2013 Jul 12.

DOI:10.1016/j.humpath.2013.05.010
PMID:23856515
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10694780/
Abstract

Trefoil factor 3 (TFF3) is associated with various cancers and overexpressed in a subset of prostate cancers. Functional studies suggest that v-ets erythroblastosis virus E26 oncogene homolog (avian) (ERG) down-regulates TFF3 expression in hormone-naïve prostate cancer. To characterize this inverse relationship, we developed a triple immunostain encompassing ERG, TFF3, and high-molecular-weight cytokeratin. Triple stain was performed on 96 tumors and 52 benign cases represented in tissue microarrays. Distinct ERG and TFF3 protein was expressed in 45% (43/96) and 36% (35/96) of prostate cancers, respectively. Coexpression was observed in 5% (5/96) of tumor cases, and 24% (23/96) did not express ERG or TFF3. The inverse expression of ERG and TFF3 was significant (P < .0001), with 57% (30/53) of ERG-negative tumors demonstrating TFF3 expression. Sensitivity and specificity of combined ERG and TFF3 expression in detecting prostate cancer were 76% and 96%, respectively. The feasibility of triple immunostain protocol was validated in a set of 76 needle biopsies. The application of this multiplex in situ biomarker for molecular characterization of prostate cancer and as a supplemental diagnostic and prognostic tool in prostate needle biopsies should be further explored.

摘要

三叶因子 3(TFF3)与多种癌症相关,在一部分前列腺癌中过度表达。功能研究表明,v-ets 红细胞生成病毒 E26 癌基因同源物(禽)(ERG)下调激素-naive 前列腺癌中的 TFF3 表达。为了描述这种反向关系,我们开发了一种包含 ERG、TFF3 和高分子量细胞角蛋白的三重免疫染色。三重染色在组织微阵列中 96 个肿瘤和 52 个良性病例中进行。分别在 45%(43/96)和 36%(35/96)的前列腺癌中观察到明显的 ERG 和 TFF3 蛋白表达。在 5%(5/96)的肿瘤病例中观察到共表达,而 24%(23/96)的病例既不表达 ERG 也不表达 TFF3。ERG 和 TFF3 的反向表达具有统计学意义(P<0.0001),57%(30/53)的 ERG 阴性肿瘤表现出 TFF3 表达。联合 ERG 和 TFF3 表达检测前列腺癌的敏感性和特异性分别为 76%和 96%。该三重免疫染色方案在 76 例针吸活检中的可行性已得到验证。这种多指标原位生物标志物在前列腺癌的分子特征分析中的应用以及作为前列腺针吸活检的辅助诊断和预后工具应进一步探索。

相似文献

1
V-ets erythroblastosis virus E26 oncogene homolog (avian)/Trefoil factor 3/high-molecular-weight cytokeratin triple immunostain: a novel tissue-based biomarker in prostate cancer with potential clinical application.V-ets 红细胞生成病毒 E26 癌基因同源物(禽)/三叶因子 3/高分子量细胞角蛋白三重免疫染色:前列腺癌的一种新的基于组织的生物标志物,具有潜在的临床应用。
Hum Pathol. 2013 Oct;44(10):2282-92. doi: 10.1016/j.humpath.2013.05.010. Epub 2013 Jul 12.
2
Clinical value of ERG, TFF3, and SPINK1 for molecular subtyping of prostate cancer.ERG、TFF3 和 SPINK1 对前列腺癌分子亚型的临床价值。
Cancer. 2015 May 1;121(9):1422-30. doi: 10.1002/cncr.29233. Epub 2015 Jan 13.
3
Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies.基于抗体的前列腺核心活检中 ERG 重排的检测,包括诊断具有挑战性的病例:前列腺核心活检中的 ERG 染色。
Arch Pathol Lab Med. 2012 Aug;136(8):935-46. doi: 10.5858/arpa.2011-0424-OA.
4
Marked heterogeneity of ERG expression in large primary prostate cancers.在大型原发性前列腺癌中 ERG 表达存在明显异质性。
Mod Pathol. 2013 Jan;26(1):106-16. doi: 10.1038/modpathol.2012.130. Epub 2012 Aug 17.
5
The utility of ERG/P63 double immunohistochemical staining in the diagnosis of limited cancer in prostate needle biopsies.ERG/P63 双重免疫组化染色在前列腺针芯活检中局限性癌诊断中的应用。
Am J Surg Pathol. 2011 Jul;35(7):1062-8. doi: 10.1097/PAS.0b013e318215cc03.
6
βIII-tubulin overexpression is an independent predictor of prostate cancer progression tightly linked to ERG fusion status and PTEN deletion.βIII-微管蛋白过表达是前列腺癌进展的一个独立预测因子,与 ERG 融合状态和 PTEN 缺失密切相关。
Am J Pathol. 2014 Mar;184(3):609-17. doi: 10.1016/j.ajpath.2013.11.007. Epub 2013 Dec 28.
7
Overexpression of the chromatin remodeler death-domain-associated protein in prostate cancer is an independent predictor of early prostate-specific antigen recurrence.染色质重塑酶死亡结构域相关蛋白在前列腺癌中的过表达是前列腺特异性抗原早期复发的独立预测因子。
Hum Pathol. 2013 Sep;44(9):1789-96. doi: 10.1016/j.humpath.2013.01.022. Epub 2013 May 2.
8
Expression of ERG protein, a prostate cancer specific marker, in high grade prostatic intraepithelial neoplasia (HGPIN): lack of utility to stratify cancer risks associated with HGPIN.ERG 蛋白表达,前列腺癌特异性标志物,在高级别前列腺上皮内瘤变(HGPIN)中的表达:对 HGPIN 相关癌症风险分层无作用。
BJU Int. 2012 Dec;110(11 Pt B):E751-5. doi: 10.1111/j.1464-410X.2012.11557.x. Epub 2012 Oct 9.
9
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.ERG 与雄激素受体在调控前列腺癌疾病进展中的三叶因子 3 中起协同作用。
Neoplasia. 2010 Dec;12(12):1031-40. doi: 10.1593/neo.10866.
10
ERG protein expression in human tumors detected with a rabbit monoclonal antibody.用兔单克隆抗体检测人肿瘤中的 ERG 蛋白表达。
Am J Clin Pathol. 2012 Dec;138(6):803-10. doi: 10.1309/AJCP3K5VUFALZTKC.

引用本文的文献

1
PTEN, ERG, SPINK1, and TFF3 Status and Relationship in a Prostate Cancer Cohort from Jordanian Arab Population.PTEN、ERG、SPINK1 和 TFF3 状态及其在约旦阿拉伯人群前列腺癌队列中的关系。
Medicina (Kaunas). 2024 Jan 18;60(1):174. doi: 10.3390/medicina60010174.
2
HOXB13 and TFF3 can contribute to the prognostic stratification of prostate adenocarcinoma.HOXB13 和 TFF3 可有助于前列腺腺癌的预后分层。
Rom J Morphol Embryol. 2021 Jan-Mar;62(1):41-52. doi: 10.47162/RJME.62.1.04.
3
Exosomes Derived from miR-143-Overexpressing MSCs Inhibit Cell Migration and Invasion in Human Prostate Cancer by Downregulating TFF3.源自过表达miR-143的间充质干细胞的外泌体通过下调TFF3抑制人前列腺癌中的细胞迁移和侵袭。
Mol Ther Nucleic Acids. 2019 Dec 6;18:232-244. doi: 10.1016/j.omtn.2019.08.010. Epub 2019 Aug 16.
4
Research status and progress of the RNA or protein biomarkers for prostate cancer.前列腺癌RNA或蛋白质生物标志物的研究现状与进展
Onco Targets Ther. 2019 Mar 22;12:2123-2136. doi: 10.2147/OTT.S194138. eCollection 2019.
5
Comprehensive Evaluation of TFF3 Promoter Hypomethylation and Molecular Biomarker Potential for Prostate Cancer Diagnosis and Prognosis.全面评估 TFF3 启动子低甲基化及其作为前列腺癌诊断和预后分子生物标志物的潜力。
Int J Mol Sci. 2017 Sep 20;18(9):2017. doi: 10.3390/ijms18092017.

本文引用的文献

1
Highly specific targeting of the TMPRSS2/ERG fusion gene using liposomal nanovectors.利用脂质体纳米载体实现 TMPRSS2/ERG 融合基因的高特异性靶向。
Clin Cancer Res. 2012 Dec 15;18(24):6648-57. doi: 10.1158/1078-0432.CCR-12-2715. Epub 2012 Oct 10.
2
Antibody-based detection of ERG rearrangements in prostate core biopsies, including diagnostically challenging cases: ERG staining in prostate core biopsies.基于抗体的前列腺核心活检中 ERG 重排的检测,包括诊断具有挑战性的病例:前列腺核心活检中的 ERG 染色。
Arch Pathol Lab Med. 2012 Aug;136(8):935-46. doi: 10.5858/arpa.2011-0424-OA.
3
ERG rearrangement for predicting subsequent cancer diagnosis in high-grade prostatic intraepithelial neoplasia and lymph node metastasis.ERG 重排预测高级别前列腺上皮内瘤变和淋巴结转移后的癌症诊断。
Clin Cancer Res. 2012 Aug 1;18(15):4163-72. doi: 10.1158/1078-0432.CCR-11-2449. Epub 2012 Jun 13.
4
ERG gene rearrangement status in prostate cancer detected by immunohistochemistry.免疫组织化学检测前列腺癌中的 ERG 基因重排状态。
Virchows Arch. 2011 Oct;459(4):441-7. doi: 10.1007/s00428-011-1128-4. Epub 2011 Jul 20.
5
Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas.免疫组织化学法检测 ERG 表达可作为前列腺腺癌中 TMPRSS2-ERG 融合检测的替代方法。
Am J Surg Pathol. 2011 Jul;35(7):1014-20. doi: 10.1097/PAS.0b013e31821e8761.
6
Mechanistic rationale for inhibition of poly(ADP-ribose) polymerase in ETS gene fusion-positive prostate cancer.ETS 基因融合阳性前列腺癌中抑制聚(ADP-核糖)聚合酶的作用机制。
Cancer Cell. 2011 May 17;19(5):664-78. doi: 10.1016/j.ccr.2011.04.010.
7
Antibody EPR3864 is specific for ERG genomic fusions in prostate cancer: implications for pathological practice.抗体 EPR3864 特异性识别前列腺癌中的 ERG 基因组融合:对病理实践的影响。
Mod Pathol. 2011 Aug;24(8):1128-38. doi: 10.1038/modpathol.2011.65. Epub 2011 Apr 15.
8
The genomic complexity of primary human prostate cancer.原发性人类前列腺癌的基因组复杂性。
Nature. 2011 Feb 10;470(7333):214-20. doi: 10.1038/nature09744.
9
ERG cooperates with androgen receptor in regulating trefoil factor 3 in prostate cancer disease progression.ERG 与雄激素受体在调控前列腺癌疾病进展中的三叶因子 3 中起协同作用。
Neoplasia. 2010 Dec;12(12):1031-40. doi: 10.1593/neo.10866.
10
The ability of biomarkers to predict systemic progression in men with high-risk prostate cancer treated surgically is dependent on ERG status.生物标志物预测接受手术治疗的高危前列腺癌男性发生全身进展的能力取决于 ERG 状态。
Cancer Res. 2010 Nov 15;70(22):8994-9002. doi: 10.1158/0008-5472.CAN-10-1358. Epub 2010 Nov 9.